CAS: 150450-53-6 - 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-
Formula:C16H12ClN3O2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro- REF: AN-AG001MMSCAS: 150450-53-6 | 99% | To inquire | Tue 21 May 24 |
 | MBCQ REF: TM-T21965CAS: 150450-53-6 | 99.38% | 49.00 €~1,179.00 € | Tue 28 May 24 |
 | MBCQ REF: 3D-AGA45053CAS: 150450-53-6 | Min. 95% | To inquire | Mon 01 Jul 24 |
4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-
CAS:150450-53-6
Formula:
C16H12ClN3O2
Purity:
99%
Color and Shape:
Solid
Molecular weight:
313.7384
Ref: AN-AG001MMS
| 10mg | 147.00 € | |
| 25mg | 291.00 € | |
| 50mg | 617.00 € | |
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
MBCQ
CAS:150450-53-6
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.
Formula:
C16H12ClN3O2
Purity:
99.38%
Color and Shape:
Solid
Molecular weight:
313.74
Ref: TM-T21965
| 2mg | 49.00 € | |
| 5mg | 73.00 € | |
| 10mg | 118.00 € | |
| 25mg | 230.00 € | |
| 50mg | 380.00 € | |
| 100mg | 550.00 € | |
| 500mg | 1,179.00 € | |
| 1ml*10 (DMSO) | 81.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
MBCQ
CAS:150450-53-6
MBCQ is a novel compound that has been shown to be an effective treatment for …
Formula:
C16H12ClN3O2
Purity:
Min. 95%
Molecular weight:
313.74 g/mol
Ref: 3D-AGA45053
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
